Delivering end-to-end supply chain strategy and transformation
New Science, the growth engine for the biopharma industry, helped us get through the pandemic, but inevitably added complexity and cost. The industry’s ability to adapt, lead, and thrive has activated a mindset shift from operational efficiency in individual silos, to resiliency through collaboration across silos and innovation at speed. It must be a multi-disciplinary task between R&D, regulatory affairs, procurement, manufacturing, quality, logistics and supply chain planners, united to deliver and create a more agile, resilient and sustainable value chain.
Accenture has the experience to help create future-ready supply chains that deliver across three key priorities:
Discover how we can help you sustain operations today and mobilize for tomorrow’s scientific advances and growth.
According to our research, 60% of supply chain executives (pharma/biopharma/medical device) struggle to get real-time inventory and visibility from external manufacturing partners. And yet, nearly all of them plan to expand their use of contract manufacturers in the next three years. This growth and increased complexity in life sciences supply chains requires an entirely different approach to collaboration to meet the demands of New Science and personalized treatments and devices.
In this report we bring to light the similarities and differences in the challenges both parties face and share real-world examples of where digital technology can help solve collaboration pain points. The report features companies who are getting it right and four key steps to establish a new level of supply chain collaboration.
READ THE REPORTOur supply chain & operations capabilities are designed to help clients achieve visibility and act with agility now to become a more responsive and resilient organization.
A patient-centric supply chain requires that biopharma companies go beyond digitizing their supply chain and put patients at the center of operations.
As New Science grows in prominence, a new economic environment is demanding change for biopharma’s.
filter result
Managing Director – Life Sciences, Global Supply Chain and Industry X
Managing Director – Strategy & Consulting, Supply Chain & Operations, Customer-Centric Supply Chain Lead
